Ankam Inc.

08/12/2024 | Press release | Distributed by Public on 08/12/2024 12:30

Management Change/Compensation Form 8 K

Item 5.01 Changes in Control of Registrant.

On August 8, 2024, a group of investors led by Wang Wen Lung, Lin Chih Hsi, Kuo Yu Min, Sung Hsiang Yu, Wang Pao Kuei and Wang Pao Hua (the "Investor Group") entered into stock purchase agreements for the acquisition of an aggregate of 3,480,067 shares of Common Stock of the Company and acquired a controlling 77% equity stake in ANKAM Inc (the "Company") through a privately negotiated transaction.

The Investor Group purchased 3,480,067 shares of the Company's common stock at a price of USD 0.143675 per share, for a total transaction value of US$ 500,000. This transaction was financed through the Investor's Group own capital. The Purchase Agreement was fully executed and delivered, and the transaction was consummated on August 12, 2024. Consequently, the Investor Group is now able to unilaterally control the election of our board of directors, all matters upon which shareholder approval is required, and, ultimately, the direction of our Company.

The Investor Group has outlined the following strategic plans for the Company:

· Explore opportunities for international expansion and strategic partnerships
· Invest in new app development specific in health industry

In addition, on August 8, 2024, Bakur Kalichava submitted his resignation from all executive officer positions with the Company, including President, Treasurer, Director and Secretary effective immediately.

On August 8, 2024, Enrike Bokuchava submitted his resignation from independent director with the Company effective immediately.